Neuroone Medical Technologies Corporation2024财年实现净利润-12.32百万美元,同比减少3.88% 市场透视12/19 08:00 NeuroOne 医疗公司的股票在公司报告了2024财年年度业绩同比增长,并发布了2025财年产品营业收入指导预期同比增长后,交易价格上涨。 NeuroOne医疗股价上涨,因为公司报告了2024财年年度业绩同比增长,并对2025财年产...
Neuroone Medical Technologies Corporation2024财年实现净利润-12.32百万美元,同比减少3.88% 市场透视2024/12/19 08:00 NeuroOne 医疗公司的股票在公司报告了2024财年年度业绩同比增长,并发布了2025财年产品营业收入指导预期同比增长后,交易价格上涨。 NeuroOne医疗股价上涨,因为公司报告了2024财年年度业绩同比增长,并对2025...
NeuroOne Medical Technologies Corporation (NMTC) 在2025财年第一季度实现显著财务增长,产品销售创下历史新高,收入大幅增加。公司股票在盘前交易中表现积极,反映出投资者对其业绩和未来前景的乐观态度。 要点摘要 NeuroOne Medical 2025财年第一季度产品销售额创纪录,达到$3.3百万。 总收入达到$6.3百万,较2024财年第一...
NeuroOne Medical Technologies Corporation(NMTC)1.097+1.57% stem(STEM)0.8648+3.73% NeuroOne Medical Technologies (NASDAQ:NMTC) announced preliminary Q1 2025 revenue to increase to $6.2M, compared to $1M in Q1 2024. Q1 2025 includes one-time $3M payment of collaboration revenue from theexpanded d...
NeuroOne Medical Technologies Corp. advanced stock charts by MarketWatch. View NMTC historial stock data and compare to other stocks and exchanges.
明尼苏达州伊甸草原 - 专注于神经系统疾病治疗的NeuroOne Medical Technologies Corporation (NASDAQ:NMTC)修订了与Zimmer Biomet的分销协议。修订后的协议授予Zimmer Biomet在美国和特定海外市场独家分销NeuroOne OneRF消融系统的权利。NeuroOne预计,这项包括300万美元预付款和潜在额外里程碑付款的交易将显著提高其收入和盈利...
NeuroOne Medical Technologies Corp. options data by MarketWatch. View NMTC option chain data and pricing information for given maturity periods.
NMTC NeuroOne Medical 添加自选 1.0700 +0.0772+7.78% 交易中 02/07 10:20 (美东) 3301.80万总市值-2.33市盈率TTM 1.0700最高价0.9972最低价6.89万股成交量1.0400今开0.9928昨收7.13万成交额0.27%换手率亏损市盈率(静)3085.79万总股本1.590052周最高39.63市净率2706.31万流通值0.551052周最低--股息TTM2529.26万流通...
NeuroOne Medical Technologies Corporation has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures. ...
Get NeuroOne Medical Technologies Corp (NMTC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.